Sutton Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5
Closed -$842 866
2023
Q1
$842 Sell
5
-6
-55% -$1.07K ﹤0.01% 742
2022
Q4
$1.86K Buy
11
+5
+83% +$907 ﹤0.01% 1215
2022
Q3
$1.12K Buy
6
+1
+20% +$211 ﹤0.01% 1265
2022
Q2
$812 Sell
5
-3
-38% -$474 ﹤0.01% 1343
2022
Q1
$1.5K Buy
8
+2
+33% +$380 ﹤0.01% 1245
2021
Q4
$1.59K Buy
+6
New +$1.62K ﹤0.01% 1235
2019
Q3
Sell
-670
Closed -$57.6K 1208
2019
Q2
$57.6K Hold
670
0.03% 273
2019
Q1
$39.6K Hold
670
0.02% 368
2018
Q4
$35.3K Hold
670
0.02% 348
2018
Q3
$37.2K Hold
670
0.02% 365
2018
Q2
$31.5K Hold
670
0.02% 417
2018
Q1
$24.2K Hold
670
0.02% 497
2017
Q4
$24.3K Hold
670
0.02% 488
2017
Q3
$25.7K Hold
670
0.02% 461
2017
Q2
$27.8K Hold
670
0.02% 425
2017
Q1
$23.6K Hold
670
0.02% 456
2016
Q4
$20.6K Hold
670
0.02% 484
2016
Q3
$20.2K Hold
670
0.02% 457
2016
Q2
$18.3K Hold
670
0.02% 467
2016
Q1
$18K Buy
+670
New +$16.4K 0.02% 469

Other funds holding RGEN

Sutton Wealth Advisors's RGEN Position: Q2 2023 in Review

Sutton Wealth Advisors sold out of Repligen (RGEN) in Q2 2023, closing a stake of 5 shares — an estimated $842 sold.

Sutton Wealth Advisors first reported a position in RGEN in Q1 2016 and held it in 20 quarters. The position peaked at $57.6K in Q2 2019. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Sutton Wealth Advisors reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 5 Repligen shares in Q2 2023, an estimated $842.
  • Sutton Wealth Advisors first reported a position in Repligen in Q1 2016 and held it in 20 quarters.
  • Sutton Wealth Advisors's Repligen position peaked at $57.6K in Q2 2019.
  • 448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Sutton Wealth Advisors's 13F filing for Q2 2023, filed 8 Nov 2023.